🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 7 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/12/1996 | 39,72 | 39,84 | 38,82 | 39,00 | -1,80% | 2,55% | 3.622.517 |
| 24/12/1996 | 39,96 | 40,02 | 39,60 | 39,72 | +0,30% | 1,04% | 1.652.906 |
| 23/12/1996 | 39,42 | 39,72 | 39,24 | 39,60 | +0,45% | 1,21% | 3.295.122 |
| 20/12/1996 | 39,60 | 39,66 | 39,18 | 39,42 | +1,69% | 1,20% | 12.259.923 |
| 19/12/1996 | 37,69 | 38,82 | 37,57 | 38,76 | +5,69% | 3,32% | 7.936.923 |
| 18/12/1996 | 36,98 | 37,33 | 36,68 | 36,68 | +0,82% | 1,77% | 5.952.430 |
| 17/12/1996 | 36,02 | 36,74 | 35,90 | 36,38 | +0,49% | 2,32% | 5.454.630 |
| 16/12/1996 | 37,03 | 37,33 | 36,08 | 36,20 | -1,78% | 3,38% | 3.948.654 |
| 13/12/1996 | 36,26 | 37,39 | 36,26 | 36,86 | +1,31% | 3,13% | 6.771.757 |
| 12/12/1996 | 37,93 | 37,99 | 36,38 | 36,38 | -3,63% | 4,25% | 4.645.574 |
| 11/12/1996 | 37,57 | 37,87 | 37,27 | 37,75 | -0,63% | 1,59% | 3.906.944 |
| 10/12/1996 | 38,41 | 38,41 | 37,93 | 37,99 | -0,93% | 1,24% | 2.546.640 |
| 09/12/1996 | 37,45 | 38,35 | 37,45 | 38,35 | +2,88% | 2,39% | 3.933.354 |
| 06/12/1996 | 36,44 | 37,81 | 35,96 | 37,27 | -1,42% | 5,07% | 7.944.050 |
| 05/12/1996 | 37,93 | 38,53 | 37,51 | 37,81 | -1,86% | 2,67% | 4.741.990 |
| 04/12/1996 | 38,47 | 38,53 | 37,81 | 38,53 | -0,31% | 1,86% | 7.097.056 |
| 03/12/1996 | 39,12 | 39,66 | 38,53 | 38,65 | -1,52% | 2,90% | 4.454.000 |
| 02/12/1996 | 39,36 | 39,48 | 39,18 | 39,24 | -0,90% | 0,76% | 2.614.131 |
| 29/11/1996 | 39,78 | 39,90 | 39,60 | 39,60 | -0,90% | 0,75% | 1.501.784 |
| 27/11/1996 | 39,96 | 40,08 | 39,60 | 39,96 | +0,15% | 1,19% | 3.920.568 |
| 26/11/1996 | 39,96 | 40,20 | 39,84 | 39,90 | -0,74% | 0,90% | 7.204.790 |
| 25/11/1996 | 39,48 | 40,20 | 39,48 | 40,20 | +1,81% | 1,81% | 4.169.154 |
| 22/11/1996 | 39,06 | 39,48 | 38,94 | 39,48 | +1,07% | 1,37% | 2.866.280 |
| 21/11/1996 | 39,42 | 39,78 | 38,82 | 39,06 | -0,76% | 2,42% | 5.106.694 |
| 20/11/1996 | 38,94 | 39,48 | 38,94 | 39,36 | +0,92% | 1,38% | 4.511.640 |
| 19/11/1996 | 38,88 | 39,12 | 38,65 | 39,00 | +0,15% | 1,23% | 4.293.866 |
| 18/11/1996 | 39,12 | 39,18 | 38,47 | 38,94 | -0,46% | 1,83% | 4.073.995 |
| 15/11/1996 | 39,06 | 39,48 | 38,88 | 39,12 | +0,77% | 1,53% | 6.167.270 |
| 14/11/1996 | 38,41 | 38,88 | 38,35 | 38,82 | +1,88% | 1,40% | 4.691.477 |
| 13/11/1996 | 37,93 | 38,53 | 37,87 | 38,11 | +0,31% | 1,73% | 4.147.146 |